CXCL9 and neoplasm: In vivo, tumor growth was rescued by specific knockdown of Cxcl9&10 in Sin3B‐deficient PDAC cells, accompanied by a significant decrease in tumoral infiltrating CD8+ T cells (Figure 4L–N).